Tech Company Inital Public Offerings

Evoke Pharma IPO

Evoke Pharma was acquired by . Shares were listed on 9/25/2013.

Transaction Overview

Company Name
Announced On
9/25/2013
Transaction Type
IPO
Amount
$25,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
420 Stevens Ave. 370
Solana Beach, CA 92075
USA
Email Address
Overview
Evoke Pharma develops therapeutics for the treatment of gastrointestinal diseases.
Profile
Evoke Pharma LinkedIn Company Profile
Social Media
Evoke Pharma Company Twitter Account
Company News
Evoke Pharma News
Facebook
Evoke Pharma on Facebook
YouTube
Evoke Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dave Gonyer
  Dave Gonyer LinkedIn Profile  Dave Gonyer Twitter Account  Dave Gonyer News  Dave Gonyer on Facebook
Chief Medical Officer
Marilyn Carlson
  Marilyn Carlson LinkedIn Profile  Marilyn Carlson Twitter Account  Marilyn Carlson News  Marilyn Carlson on Facebook
VP - Bus. Development
Matthew D'Onofrio
  Matthew D'Onofrio LinkedIn Profile  Matthew D'Onofrio Twitter Account  Matthew D'Onofrio News  Matthew D'Onofrio on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/25/2013: BetterCloud venture capital transaction
Next: 9/25/2013: Varentec venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary